Skip to content Skip to sidebar Skip to footer

Newsletter

Nick Sundich

1,217 articles published

Biotech Stocks Healthcare Stocks

Kidney disease-focused biotech Dimerix announced a US licensing deal for DMX-200! And this could be the best deal of all!

Dimerix has been targeting a US licensing deal for DMX-200 and the dreams are now a reality as of this morning! The company already had licensing deals with 2 companies for other jurisdictions, but not for the US (or China) which were and are larger opportunities. But this morning, it unveiled the deal to shareholders…

ByNick SundichMay 1, 20250Comments

Resources

4 key metrics in resources projects that investors need to be aware of

There are several key metrics in resources projects that investors considering junior mining & resources stocks need to consider. However, there are a handful that are more important than others, and we thought we would highlight the 4 most important. 4 key metrics in resources projects that investors need to be aware of NPV The Net…

ByNick SundichMay 1, 20250Comments

General Market news Mid Cap Stocks Small Caps Stocks

PointsBet (ASX:PBH): After failing to crack the lucrative US market, its now the subject of a takeover war

PointsBet (ASX:PBH) investors have had a tumultous 24 hours, first in hearing that Matt Tripp's Betr (listed on the ASX through its merger with BlueBet) had bought 19.9% of the company, and then hours later that it intends to buy the rest of the company. And all this after having previously agreed to another takeover…

ByNick SundichMay 1, 20250Comments

Uncategorized

Here are 4 useful retirement investment portfolio diversification tips

Retirement investment portfolio diversification is an essential strategy for any investor seeking to reduce risk and maximise returns. But how can you achieve it? Retirement investment portfolio diversification is important But what is it? Diversification generally involves spreading your investments across various asset classes, sectors, and geographical locations. A diversified investment portfolio typically includes a mix…

ByNick SundichApril 30, 20250Comments

Energy Stocks Oil and Gas Stocks

Woodside is proceeding with Louisiana LNG! But it won’t come cheap with a US$11.8bn price tag

Yesterday, Woodside Energy (ASX:WDS) revealed that Louisiana LNG is go! The company has made a final investment decision on the project, which it expects to derive the first LNG from in 2029. It won't come cheap...but the company thinks it'll be worth the price tag. Louisiana LNG: A high price tag, but potentially high returns The…

ByNick SundichApril 30, 20250Comments

Financials

The ASX CHESS Replacement: Will the excruciating wait finally be over by the end of the 2020s?

The long-promised ASX CHESS replacement has been a saga that likely has more twists and turns to come. Despite prior hopes we could've had it in April 2023, it may not be until the end of this decade. So, why have things gone so wrong, will we ever see it and where are things at as…

ByNick SundichApril 29, 20250Comments

General

5 stock moves that Wilson Asset Management made recently

Wilson Asset Management is one of the most prominent institutional investors on the ASX. It was founded by, named after and is still led by Geoff Wilson, one of the most famous investors in Australia. Wilson is also one of the easiest to follow stock movements because, as it has 8 Listed Investment Companies (LICs) on…

ByNick SundichApril 29, 20250Comments

Blue Chip Stocks Industrials

As the backlash towards James Hardie continues, the company has broken its silence

There's been a backlash towards James Hardie in the past few weeks that has nothing to do with its tortured history in asbestos. Why the backlash towards James Hardie? The backlash has been about James Hardie's US$8.8bn/A$14bn deal to buy Azek, a manufacturer of outdoor living furniture (think deck chairs, railing and floorboards as examples). Or…

ByNick SundichApril 28, 20250Comments

Blue Chip Stocks Education

Here are 6 of the best mergers and acquisitions on the ASX and 6 of the worst deals!

Mergers and acquisitions on the ASX happen all the time. From the perspective of the company being bought out, they will often be content with the cash, but may occasionally perceive that they could make more cash by 'fighting the good fight' themselves. From the buyer's perspective, it is always a case of 'caveat emptor', buyer…

ByNick SundichApril 28, 20250Comments

Healthcare Stocks

Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!

What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful story? It would have been possible believe back in those days, but it was still far from certain it would be the case. The recent example of Opthea shows biotech is a risky business and…

ByNick SundichApril 24, 20250Comments

the Kick-ass Multipurpose WordPress Theme

Nick Sundich

Kidney disease-focused biotech Dimerix announced a US licensing deal for DMX-200! And this could be the best deal of all!

4 key metrics in resources projects that investors need to be aware of

PointsBet (ASX:PBH): After failing to crack the lucrative US market, its now the subject of a takeover war

Here are 4 useful retirement investment portfolio diversification tips

Woodside is proceeding with Louisiana LNG! But it won’t come cheap with a US$11.8bn price tag

The ASX CHESS Replacement: Will the excruciating wait finally be over by the end of the 2020s?

5 stock moves that Wilson Asset Management made recently

As the backlash towards James Hardie continues, the company has broken its silence

Here are 6 of the best mergers and acquisitions on the ASX and 6 of the worst deals!

Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Nick Sundich

Add Your Heading Text Here